Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents

Systemic inflammation represents a shared pathophysiological mechanism which underlies the frequent clinical associations among chronic inflammatory rheumatic diseases (CIRDs), insulin resistance, type 2 diabetes (T2D), and chronic diabetes complications, including cardiovascular disease. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Infante, Marco, Padilla, Nathalia, Alejandro, Rodolfo, Caprio, Massimiliano, Della-Morte, David, Fabbri, Andrea, Ricordi, Camillo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143119/
https://www.ncbi.nlm.nih.gov/pubmed/35629988
http://dx.doi.org/10.3390/medicina58050571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143119/
https://www.ncbi.nlm.nih.gov/pubmed/35629988
http://dx.doi.org/10.3390/medicina58050571

Ejemplares similares